Inhibition of TGFβ improves hematopoietic stem cell niche and ameliorates cancer-related anemia.
Boyan WangYi WangHainan ChenSenyu YaoXiaofan LaiYuan QiuJianye CaiYinong HuangXiaoyue WeiYuanjun GuanTao WangJiancheng WangAndy Peng XiangPublished in: Stem cell research & therapy (2021)
This study investigated the role of TGFβ released by bone remodeling in the progression of cancer-related anemia and revealed a potential therapeutic approach for relieving defects in hematopoiesis.